Barclays’s Biomerica BMRA Stock Holding History
Bought
Maintained
Sold
Other funds holding BMRA
Barclays's BMRA Position: Q3 2026 in Review
Barclays sold out of Biomerica (BMRA) in Q3 2026, closing a stake of 6 shares — an estimated $11 sold.
Barclays first reported a position in BMRA in Q3 2018 and held it in 6 quarters. The position peaked at $363K in Q2 2020. 21 funds tracked by Wall St. Rank hold BMRA as of Q3 2026.
- Barclays reported no remaining Biomerica position as of Q3 2026 after selling out during the quarter.
- Barclays sold 6 Biomerica shares in Q3 2026, an estimated $11.
- Barclays first reported a position in Biomerica in Q3 2018 and held it in 6 quarters.
- Barclays's Biomerica position peaked at $363K in Q2 2020.
- 21 funds tracked by Wall St. Rank held Biomerica as of Q3 2026.
Based on Barclays's 13F filing for Q3 2026, filed 6 Nov 2026.